Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 512 Million DKK | -71.01% |
| 2022 | 1.76 Billion DKK | 132.37% |
| 2021 | 760 Million DKK | -45.75% |
| 2020 | 1.4 Billion DKK | 21.72% |
| 2019 | 1.15 Billion DKK | -11.73% |
| 2018 | 1.3 Billion DKK | 1471.08% |
| 2017 | 83 Million DKK | -91.03% |
| 2016 | 925 Million DKK | 32.14% |
| 2015 | 700 Million DKK | -0.28% |
| 2014 | 702 Million DKK | -6.77% |
| 2013 | 753 Million DKK | 4261.17% |
| 2012 | 17.26 Million DKK | -41.56% |
| 2011 | 29.54 Million DKK | -33.08% |
| 2010 | 44.14 Million DKK | -22.89% |
| 2009 | 57.25 Million DKK | 53.06% |
| 2008 | 37.4 Million DKK | -30.34% |
| 2007 | 53.69 Million DKK | -27.15% |
| 2006 | 73.7 Million DKK | 0.53% |
| 2005 | 73.31 Million DKK | -26.38% |
| 2004 | 99.58 Million DKK | -5.13% |
| 2003 | 104.96 Million DKK | -18.82% |
| 2002 | 129.29 Million DKK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 535 Million DKK | 0.0% |
| 2024 Q2 | 557 Million DKK | 0.0% |
| 2024 Q1 | 554 Million DKK | 0.0% |
| 2023 Q3 | 665 Million DKK | -20.17% |
| 2023 Q1 | 1.86 Billion DKK | 5.32% |
| 2023 FY | 512 Million DKK | -71.01% |
| 2023 Q4 | 512 Million DKK | -23.01% |
| 2023 Q2 | 833 Million DKK | -55.22% |
| 2022 Q1 | 1.31 Billion DKK | 73.16% |
| 2022 Q3 | 1.47 Billion DKK | 1.16% |
| 2022 Q4 | 1.76 Billion DKK | 19.49% |
| 2022 FY | 1.76 Billion DKK | 132.37% |
| 2022 Q2 | 1.46 Billion DKK | 11.02% |
| 2021 Q1 | 1.8 Billion DKK | 28.77% |
| 2021 Q3 | 202 Million DKK | -63.73% |
| 2021 FY | 760 Million DKK | -45.75% |
| 2021 Q2 | 557 Million DKK | -69.12% |
| 2021 Q4 | 760 Million DKK | 276.24% |
| 2020 Q1 | 1.45 Billion DKK | 26.76% |
| 2020 FY | 1.4 Billion DKK | 21.72% |
| 2020 Q2 | 1.45 Billion DKK | -0.48% |
| 2020 Q4 | 1.4 Billion DKK | 8.86% |
| 2020 Q3 | 1.28 Billion DKK | -11.36% |
| 2019 Q4 | 1.15 Billion DKK | 2.31% |
| 2019 Q1 | 1.35 Billion DKK | 3.76% |
| 2019 Q2 | 1.3 Billion DKK | -3.7% |
| 2019 FY | 1.15 Billion DKK | -11.73% |
| 2019 Q3 | 1.12 Billion DKK | -13.66% |
| 2018 FY | 1.3 Billion DKK | 1471.08% |
| 2018 Q1 | 332 Million DKK | 300.0% |
| 2018 Q3 | 1.43 Billion DKK | 5.45% |
| 2018 Q4 | 1.3 Billion DKK | -8.87% |
| 2018 Q2 | 1.35 Billion DKK | 308.73% |
| 2017 Q3 | 208 Million DKK | -32.9% |
| 2017 FY | 83 Million DKK | -91.03% |
| 2017 Q1 | 1.08 Billion DKK | 17.19% |
| 2017 Q2 | 310 Million DKK | -71.4% |
| 2017 Q4 | 83 Million DKK | -60.1% |
| 2016 Q1 | 700 Million DKK | 0.0% |
| 2016 Q2 | 975 Million DKK | 39.29% |
| 2016 Q3 | 876 Million DKK | -10.15% |
| 2016 Q4 | 925 Million DKK | 5.59% |
| 2016 FY | 925 Million DKK | 32.14% |
| 2015 Q4 | 700 Million DKK | 0.0% |
| 2015 FY | 700 Million DKK | -0.28% |
| 2015 Q3 | 700 Million DKK | 0.0% |
| 2015 Q2 | 700 Million DKK | -0.14% |
| 2015 Q1 | 701 Million DKK | -0.14% |
| 2014 Q1 | 704 Million DKK | -6.51% |
| 2014 Q2 | 703 Million DKK | -0.14% |
| 2014 Q4 | 702 Million DKK | 0.0% |
| 2014 Q3 | 702 Million DKK | -0.14% |
| 2014 FY | 702 Million DKK | -6.77% |
| 2013 Q3 | 755.6 Million DKK | -0.25% |
| 2013 FY | 753 Million DKK | 4261.17% |
| 2013 Q4 | 753 Million DKK | -0.34% |
| 2013 Q2 | 757.5 Million DKK | 0.0% |
| 2013 Q1 | - DKK | -100.0% |
| 2012 Q4 | 17.26 Million DKK | 0.0% |
| 2012 Q1 | - DKK | -100.0% |
| 2012 Q2 | - DKK | 0.0% |
| 2012 Q3 | - DKK | 0.0% |
| 2012 FY | 17.26 Million DKK | -41.56% |
| 2011 FY | 29.54 Million DKK | -33.08% |
| 2011 Q3 | - DKK | 0.0% |
| 2011 Q2 | - DKK | 0.0% |
| 2011 Q1 | - DKK | -100.0% |
| 2011 Q4 | 29.54 Million DKK | 0.0% |
| 2010 Q3 | - DKK | 0.0% |
| 2010 FY | 44.14 Million DKK | -22.89% |
| 2010 Q2 | - DKK | 0.0% |
| 2010 Q1 | - DKK | -100.0% |
| 2010 Q4 | 44.14 Million DKK | 0.0% |
| 2009 Q4 | 57.25 Million DKK | 0.0% |
| 2009 FY | 57.25 Million DKK | 53.06% |
| 2008 FY | 37.4 Million DKK | -30.34% |
| 2007 FY | 53.69 Million DKK | -27.15% |
| 2006 FY | 73.7 Million DKK | 0.53% |
| 2005 FY | 73.31 Million DKK | -26.38% |
| 2004 FY | 99.58 Million DKK | -5.13% |
| 2003 FY | 104.96 Million DKK | -18.82% |
| 2002 FY | 129.29 Million DKK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -113808.646% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | -64.207% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | -2614.513% |
| Össur hf. | 311.8 Million USD | -64.207% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | -183147.198% |
| Aurora Spine Corporation | 1.59 Million USD | -32064.582% |
| BrainsWay Ltd. | 239 Thousand USD | -214125.941% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | -3986.313% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -2964.794% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -235182.224% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -1172168.523% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.89 Million USD | -13040.159% |
| Nanomix Corporation | 10.11 Million USD | -4963.561% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -82747.896% |
| Theraclion SA | 1.95 Million EUR | -26146.504% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -341233.333% |
| Lombard Medical, Inc. | 28.02 Million USD | -1726.94% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | -473.633% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -210351.031% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 37.117% |
| VMS Rehab Systems, Inc. | 106.45 USD | -480976884.5% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -100095.695% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -96090.698% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -86679.661% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -167989.297% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -103965.041% |
| IR-Med Inc. | 161 Thousand USD | -317912.422% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -359629.922% |
| Polarean Imaging plc | 74.84 Thousand USD | -683971.293% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -63581.592% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -158707.948% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -441073.936% |
| Urologix, Inc. | 4.58 Million USD | -11064.413% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -118904.73% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -18275.432% |
| SS Innovations International, Inc. | 1.91 Million USD | -26700.221% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 76.426% |
| NIOX Group Plc | 500 Thousand USD | -102300.0% |
| Fuse Medical, Inc. | 200 Thousand USD | -255900.0% |
| Broncus Holding Corporation | 1.22 Million USD | -41730.065% |
| Brain Scientific Inc. | 7378.00 USD | -6939450.014% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -316214.931% |
| Health Logic Interactive Inc. | - USD | -Infinity% |